Abstract
The interferon (IFN)-induced, double stranded RNA (dsRNA)-activated serine/threonine kinase, PKR, is a potent negative regulator of cell growth when overexpressed in yeast or mammalian cells. To determine whether endogenous PKR plays a role in cell growth control, we have investigated the regulation of PKR levels and activity during the cell cycle in human glioblastoma T98G cells. The steady-state level of PKR mRNA in T98G cells was highest in growth arrested cells, dropped sharply within 3 h of serum stimulation then gradually increased as cells progressed through G1, reaching a plateau in early S phase. PKR protein level increased following serum stimulation reaching a peak at the G2+M boundary and declining thereafter. In contrast, PKR kinase activity exhibited two peaks, in early G1 and at the G1/S boundary, declining sharply in early S phase. Thus, the activity profile did not follow the protein profile indicating a tight regulation of PKR at the level of activity. In T98G cells expressing the catalytically inactive PKRK296R the dsRNA-induced activation of NF-κB and IRF-1 was suppressed and the mutant cells exhibited resistance to stress induced apoptosis. Cell cycle distribution analysis showed that the mutant expressing cells exhibited longer G1 phase and fewer cells engaged in S phase. Furthermore, early passage mouse embryo fibroblasts derived from PKR knockout mice grew more slowly compared with the control cells. Taken together these results suggest that PKR may play a role in cell cycle progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barber GN, Thompson S, Lee TG, Strom T, Jagus R, Darveau A and Katze MG. . 1994 Proc. Natl. Acad. Sci. USA 91: 4278–4282.
Barber GN, Wambach M, Thompson S, Jagus R and Katze MG. . 1995 Mol. Cell. Biol. 15: 3138–3146.
Benkirane M, Neuveut C, Chun RFM, Smith SM, Samuel CE, Gatignol A and Jeang K-T. . 1997 EMBO J. 16: 611–624.
Burke LC, Bybee A and Thomas NS. . 1992 Oncogene 7: 783–788.
Bybee A and Thomas NS. . 1992 Biochim. Biophys. Acta. 1137: 73–76.
Carpick BW, Graziano V, Schneider D, Maitra RK, Lee X and Williams BRG. . 1997 J. Biol. Chem. 272: 9510–9516.
Chong KL, Feng L, Schappert K, Meurs EF, Donahue TF, Friesen JD, Hovanessian AG and Williams BRG. . 1992 EMBO J. 11: 1553–1562.
Chu W-M, Ballard R, Carpick BW, Williams BRG and Schmid CW. . (1998 Mol. Cell. Biol. 18: 58–68.
Der SD, Yang Y-L, Weissmann C and Williams BRG. . 1997 Proc. Natl. Acad. Sci. USA 94: 3279–3283.
Dynlacht BD, Flores O, Lees JA and Harlow E. . 1994 Genes Dev. 8: 1772–1786.
Einat M, Resnitzky D and Kimchi A. . 1985 Nature 313: 597–600.
Elledge SJ and Harper JW. . 1994 Curr. Opin. Cell. Biol. 6: 847–852.
Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J and Livingston DM. . 1993 Cell 73: 487–497.
Farrell PJ, Balkow K, Hunt T, Jackson RJ and Trachsel H. . 1977 Cell 11: 187–200.
Fieck A, Wyborski DL and Short JM. . 1992 Nucleic Acids Res. 20: 1785–1791.
Galabru J and Hovanessian AG. . 1985 Cell 4: 685–694.
Hanks SK, Quinn AM and Hunter T. . 1988 Science 241: 42–52.
Hannigan G, Williams BRG. . 1986 EMBO J. 5: 1607–1613.
Hovanessian AG and Galabru J. . 1987 Eur. J. Biochem. 167: 467–473.
Hovanessian AG. . 1993 Semin. Virol. 4: 237–245.
Iwase S, Furukawa Y, Kikuchi J, Nagai M, Terui Y, Nakamura M and Yamada H. . 1997 J. Biol. Chem. 272: 12406–12414.
Judware R and Petryshyn R. . 1991 Mol. Cell. Biol. 11: 3259–3267.
Judware R and Petryshyn R. . 1992 J. Biol. Chem. 267: 21685–21690.
Katze MG, Wambach M, Wong M-L, Garfinkel M, Meurs EF, Chong K, Williams BRG, Hovanessian AG and Barber GN. . 1991 Mol. Cell. Biol. 11: 5497–5505.
Kerr IM, Brown RE and Hovanessian AG. . 1977 Nature 268: 540–542.
Kimchi A, Resnitzky D, Ber R and Gat G. . 1988 Mol. Cell. Biol. 8: 2828–2836.
Koromilas AE, Roy S, Barber G, Katze MG and Sonenberg N. . 1992 Science 257: 1685–1689.
Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin Jr WG, Livingston DM. . 1994 Cell 78: 161–172.
Krek W, Xu G and Livingston DM. . 1995 Cell 83: 1149–1158.
Kumar A, Haque J, Lacoste J, Hiscott J and Williams BRG. . 1994 Proc. Natl. Acad. Sci. USA 91: 6288–6292.
Kumar A, Yang Y-L, Flati V, Der SD, Kadereit S, Deb A, Haque J, Reis L, Weissmann C and Williams BRG. . 1997 EMBO J. 16: 406–416.
Kumar R and Atlas I. . 1992 Proc. Natl. Acad. Sci. USA 89: 6599–6603.
La Thangue NB. . 1994 Trends Biochem. Sci. 19: 108–114.
Lee TG, Tang N, Thompson S, Miller J and Katze MG. . 1994 Mol. Cell. Biol. 14: 2331–2342.
Maran A, Maitra RK, Kumar A, Dong B, Xiao W, Li G, Williams BRG, Torrence PF and Silverman RH. . 1994 Science 265: 789–792.
Mayol X, Garriga J and Grana X. . 1995 Oncogene 11: 801–808.
McMillan NAG and Williams BRG. . 1996 Cell Growth Regulation. Clemens MJ (ed.). Harwood London.
Melamed D, Tiefenbrun N, Yarden A and Kimchi A. . 1993 Mol. Cell. Biol. 13: 5255–5265.
Melville MW, Hansen WJ, Freeman BC, Welch WJ and Katze MG. . 1997 Proc. Natl. Acad. Sci. USA 94: 97–102.
Meurs EF, Chong K, Galabru J, Thomas NSB, Kerr I, Williams BRG and Hovanessian AG. . 1990 Cell 62: 379–390.
Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG. . 1993 Proc. Natl. Acad. Sci. USA 90: 232–236.
Meurs EF, Watanabe Y, Kadereit S, Barber GN, Katze MG, Chong K, Williams BRG and Hovanessian AG. . 1992 J. Virol. 66: 5805–5814.
Morgan DO. . 1995 Nature 374: 131–134.
Mundschau LJ and Faller DV. . 1992 J. Biol. Chem. 267: 23092–23098.
Nigg EA. . 1995 Bioessays 17: 471–480.
Park H, Davies MV, Langland JO, Chang H-W, Nam YS, Tartaglia J, Paoletti E, Jacobs BL, Kaufman RJ and Venkatesan S. . 1994 Proc. Natl. Acad. Sci. USA 91: 4713–4717.
Patel RC, Stanton P and Sen GC. . 1994 J. Biol. Chem. 269: 18593–18598.
Petryshyn R, Chen J-J and London IM. . 1988 Proc. Natl. Acad. Sci. USA 85: 1427–1431.
Polyak SJ, Tang N, Wambach M, Barber GN and Katze MG. . 1996 J. Biol. Chem. 271: 1702–1707.
Proud CG. . 1995 Trends Biochem. Sci. 20: 241–246.
Raveh T, Hovanessian AG, Meurs EF, Sonenberg N and Kimchi A. . 1996 J. Biol. Chem. 271: 25479–25484.
Resnitzky D, Tiefenbrun N, Berissi H and Kimchi A. . 1992 Proc. Natl. Acad. Sci. USA 89: 402–406.
Saito S and Kawakita M. . 1991 Microbiol. Immunol. 35: 1105–1114.
Sherr CJ and Roberts JM. . 1995 Genes Dev. 9: 1149–1163.
Sherr CJ. . 1994 Cell 79: 551–555.
Stein GH. . 1979 J. Cell. Physiol. 99: 43–54.
Subramaniam PS and Johnson HM. . 1997 J. Interferon Cytokine Res. 17: 11–15.
Thomas NS, Burke LC, Bybee A and Linch DC. . 1991 Oncogene 6: 317–322.
Tiefenbrun N, Melamed D, Levy N, Resnitzky D, Hoffmann I, Reed SI and Kimchi A. . 1996 Mol. Cell. Biol. 16,: 3934–3944.
Weinberg RA. . 1995 Cell 81: 323–330.
Williams BRG. . 1995 Semin. Virol. 6: 191–202.
Yang Y-L, Reis LFL, Pavlovic J, Aguzzi A, Schafer R, Kumar A, Williams BRG, Aguet M and Weissmann C. . 1995 EMBO J. 14: 6095–6106.
Yeung MC, Liu J and Lau AS. . 1996 Proc. Natl. Acad. Sci. USA 93: 12451–12455.
Zhou A, Hassel BA and Silverman RH. . 1993 Cell 72: 753–765.
Acknowledgements
This work was supported by a grant to BRGW from the National Institutes of Health (AI34039). We thank RH Silverman and BW Carpick for comments on the manuscript and Shixing Yuan for constructing the lacI expressing T98G cell line, LacI.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zamanian-Daryoush, M., Der, S. & Williams, B. Cell cycle regulation of the double stranded RNA activated protein kinase, PKR. Oncogene 18, 315–326 (1999). https://doi.org/10.1038/sj.onc.1202293
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202293
Keywords
This article is cited by
-
HIF-1α-Dependent Gene Expression Program During the Nucleic Acid-Triggered Antiviral Innate Immune Responses
Molecules and Cells (2009)
-
Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer
BMC Cancer (2006)
-
Simultaneous detection of double-stranded RNA-induced protein kinase and its specific mRNA by single cell analysis
Biotechnology Letters (2005)
-
Targets and mechanisms for the regulation of translation in malignant transformation
Oncogene (2004)
-
Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis
Oncogene (2002)